ArticleInfectious Disease Modelling2026
Resolving parameter uncertainty in SIR models through population-level serological surveillance: A synthetic study.
Article in Infectious Disease Modelling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Epidemic models face a critical challenge: surveillance systems capture only a fraction of infections (often <10%). We reveal two fundamental problems. First, when models ignore underdetection entirely-treating detected cases as complete-parameter errors exceed 1000% despite visually reasonable fits. Second, when models explicitly account for underdetection by including case detection ratios as unknown parameters, structural identifiability analysis proves transmission rates and detection ratios become mathematically confounded-rendering infinite epidemiologically distinct scenarios equally plausible from case data alone. Integrating even a single population-level seroprevalence measurement resolves both problems by independently constraining cumulative exposure. Through Bayesian inference on synthetic SIR data, we demonstrate that this approach reduces parameter uncertainty by orders of magnitude, enabling accurate inference of transmission dynamics, peak timing, and outbreak size under realistic noise. Our framework establishes serological surveillance integration as both a mathematical necessity and a strategic investment for pandemic preparedness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.